We have studied rat vascular smooth muscle (VSM) cells in culture for the presence of key elements of the glandular kallikrein-kinin system. Direct radioimmunoassay (RIA) using antiserum against rat urinary kallikrein detected a glandular kallikrein-like enzyme (GKLE) in VSM cells and in media. VSM homogenates and culture media had kininogenase activity, generating kinins from dog kininogen. About half of the GKLE was enzymatically inactive which could be activated with trypsin. Kininogenase activity was inhibited completely by aprotinin but only 20% by soybean trypsin inhibitor (SBTI). Trypsin liberated kinins from homogenates and media, demonstrating that VSM cells contain kininogen. Homogenates and media rapidly degrade bradykinin. GKLE, kininogen, and bradykininase activity were all present in VSM cells grown in defined media that contain no serum, thus eliminating any contamination or artefacts from fetal calf serum in standard culture media.
Introduction
The glandular kallikreins (EC 3.4 .21.8) are a subgroup of serine proteases that are encoded by a multigene family (1) . The enzymes belong to a larger family of kininogenases, which yield hypotensive peptides, kinins, by limited proteolytic cleavage ofkininogen (2) . Generation of kinins is regarded as a major in vivo function of glandular kallikrein. Recent studies zymes (3) , hormones (4) , and growth factors (5) , and can degrade biologically active molecules such as atrial peptides (6) , apolipoproteins (7) , and sodium channels (8) . Although glandular kallikrein can process a variety of natural substrates, the precise physiological and pathological roles of this enzyme system are not known.
Glandular kallikrein was initially identified in urine, kidney, pancreas, and salivary glands. Recent evidence indicates that this enzyme occurs in many additional organs such as skeletal muscle (9) , erythrocytes (10) , and the central nervous system (11) . Nolly et al. (12) reported the occurrence of a glandular kallikrein-like enzyme (GKLE)' in rat vascular tissue. In the present studies we have confirmed this finding. Synthesis by vascular tissue of an enzyme that can release potent vasoactive peptides and activate growth factors is of obvious interest and potential importance. We have examined rat vascular smooth muscle (VSM) cells in culture for the presence of the kallikrein-kinin system. We report that not only GKLE, but also kininogen and kininase(s) are synthesized by VSM cells. This raises the possibility that the kallikrein system may function as an autocoid mechanism in blood vessels. Moreover, the expression of these components in cell culture should facilitate studies of the regulation of synthesis of these key elements of the kallikrein system. Methods '25I-Tyr8-bradykinin and sodium 1251 (New England Nuclear, Boston, MA), Tosyl phenylalanine chloromethyl ketone (TPCK) treated trypsin and soybean trypsin inhibitor (Sigma Chemical Co., St. Louis), and platelet derived growth factor (PDGF), (New England Biolabs, Inc., Cambridge, MA) were obtained from commercial sources as indicated. An 
Preparation ofrat aorta homogenate
Male Sprague-Dawley rats were anesthetized with pentobarbital and injected with 0.1 ml heparin (5,000 U/ml) into the vena cava. The heart was cut and used to lift aorta. The aorta was cut and placed in a petri dish containing saline. The Kallikrein was determined using our direct RIA (15). Standard curves were developed using '25I-kallikrein and rabbit anti-rat urinary kallikrein antibody. Our antibody is extensively characterized ( 16) and is known to recognize active as well as inactive kallikrein (total kallikrein).
Kininogenase assay
Kininogenase activity was determined using our microkininogenase assay (17) . Briefly, tissue homogenates or media were incubated with partially purified dog kininogen for 24 h. The liberated kinins were purified by ethanol extraction and assayed by kinin RIA.
Kinin-RIA Our kinin RIA has been published (18) . Briefly, we use 1251_ Tyr8-bradykinin as an antigen and highly sensitive antibradykinin serum to develop the standard curve. The least detectable amount of kinin in this RIA is 1 pg/tube. Kininogen determination
The tissue homogenates or media were incubated with TPCK-trypsin (16, 19) . The reaction was terminated by placing the tubes in a boiling water bath and the generated kinins were isolated and estimated by the kinin-RIA.
Kininase assay
We used '251-Tyr8-bradykinin as a substrate and the loss in immunoreactivity of this radiolabelled bradykinin with kinin antibody as the index of kinin degradation.
Protein determination
Protein microassay (Bio-Rad Chemical Division, Richmond, CA) was used according to the directions of the manufacturer to estimate proteins.
Results
Rat aorta. Blood-free rat aorta homogenate contained 15.4 ± 3.2 (SD) ng GKLE/mg protein (n = 3). Aorta denuded of endothelium contained 15.2 ± 4.2 ng/mg (n = 3). Immunologically, GKLE was similar to rat urinary kallikrein as demonstrated by displacements of '251-kallikrein-antikallikrein conjugate (Fig. 1) .
In Qualitatively, homogenates of cells grown in primary culture invariably generated kinins upon incubation with dog kininogen suggesting the occurrence of kininogenase activity in VSM cells. Since quantitation and a complete assessment of the nature of kininogenase activity require a large amount of sample, the full analysis was performed in two representative batches; one grown in defined media and the other in regular Kl media. The homogenate ofthe VSM cells grown in defined media generated 32.5 ng kinins/mg protein/24 h. After treatment of the homogenate with trypsin to activate inactive kallikrein, 58.8 ng/mg per 24 h were generated. Thus, -55% of GKLE appeared to be in active and 45% in an inactive form. This kininogenase activity (active form) was entirely inhibited by addition of 10 gg aprotinin during incubation. No kinins kininogen (15, 18) . A batch of primary culture VSM grown in defined media contained 21.5 ng/mg kininogen. Kininogen was also detected in three media from primary cultures (Table I) ; two were regular media, one was a defined medium.
Bradykininase(s). As shown in Fig. 3 , '25I-bradykinin was rapidly degraded when it was incubated with intact VSM cells in primary culture. Bradykinin was not degraded by prolonged incubation with medium alone (control, Fig. 3 (Fig. 2) . Moreover, kininogenase activity of VSM homoge- nates is completely inhibited by aprotinin but is inhibited only 20% by SBTI. Our data suggest that about one-half of GKLE in VSM is in an inactive form that can be activated by trypsin. This is consistent with glandular kallikrein in rat urine (16) . Since aorta denuded of endothelium had the same amount of GKLE as intact aorta in our study and Hial et al. (20) did not find kallikrein in human endothelial cells in culture, it is likely that VSM cells are the principal and possibly the only type of vascular cells that make kallikrein.
We detected GKLE both in primary cultures and in an established VSM cell line. GKLE was also readily detected in VSM cells grown in a defined medium. This eliminates the possibility that the GKLE detected in VSM cells grown in regular media, which contain fetal calf serum, is a contaminant from the calfserum. Indeed, the content ofGKLE tended to be higher in VSM cells grown in defined than in regular media. We speculate that growth factors added to the defined media (PDGF, insulin, and cortisol) may stimulate synthesis of GKLE.
We also have found that VSM cells in culture synthesize kininogen and bradykininase(s) activity. All three components are secreted into culture media. Thus, all the key components of the kallikrein system are present in arterial tissue, where they may function as an autocrine system. Kinins liberated locally may help regulate vascular tone. Kallikrein itself processes growth factors, hormones and other proteins and thereby may help modulate growth and function of VSM cells or nearby endothelial cells. If the kallikrein system components are released into the blood in vivo as they are into the medium in cell cultures, they may affect resistance vessels downstream. The tone of resistance vessels also may be modulated locally by the kallikrein system, if smooth muscle cells of resistance vessels themselves synthesize the key components.
